Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

Fever and rash can be early signs of lupus.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New treatments for lupus show promise, but more research is needed, especially for children.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

A woman with lupus had rare severe symptoms but improved with treatment.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.